Hypertension Research Today is a free monthly online journal that collates and summarizes the latest research about Hypertension, including details on symptoms, diagnosis, diet, treatment, causes.

Volume 5 (2008), Issue 3 (March)

1. Doxazosin in the current treatment of hypertension.
   Expert Opin Pharmacother, 9(4): 625-33. [Abstract] [Full-text]
2. Spironolactone versus eplerenone for the treatment of idiopathic hyperaldosteronism.
   Expert Opin Pharmacother, 9(4): 509-15. [Abstract] [Full-text]
3. Self-care and adherence to medication: a survey in the hypertension outpatient clinic.
   BMC Complement Altern Med, 8: 4. [Abstract] [Full-text]
4. Increased plasma aldosterone-to-renin ratio is associated with impaired left ventricular longitudinal functional reserve in patients with uncomplicated hypertension.
   J Am Soc Echocardiogr, 21(3): 251-6. [Abstract] [Full-text]
5. Effect of geometric remodeling on left ventricular longitudinal contractile reserve in patients with hypertension.
   J Am Soc Echocardiogr, 21(3): 246-50. [Abstract] [Full-text]
6. Antihypertensive effect of biotin in stroke-prone spontaneously hypertensive rats.
   Br J Nutr, 99(4): 756-63. [Abstract] [Full-text]
7. Effect of immunisation against angiotensin II with CYT006-AngQb on ambulatory blood pressure: a double-blind, randomised, placebo-controlled phase IIa study.
   Lancet, 371(9615): 821-7. [Abstract] [Full-text]
8. Systolic hypertension in the elderly: addressing an unmet need.
   Am J Med, 121(3): 179-184.e3. [Abstract] [Full-text]
9. Aliskiren-hydrochlorothiazide combination for the treatment of hypertension.
   Expert Rev Cardiovasc Ther, 6(3): 305-14. [Abstract] [Full-text]
10. Treatment of hypertension in individuals with the cardiometabolic syndrome: role of an angiotensin II receptor blocker, telmisartan.
    Expert Rev Cardiovasc Ther, 6(3): 289-303. [Abstract] [Full-text]
11. Effects of oolong tea on renal sympathetic nerve activity and spontaneous hypertension in rats.
    Metabolism, 57(4): 526-34. [Abstract] [Full-text]
12. Changes in cardiovascular parameters and plasma norepinephrine level in rats after chronic constriction injury on the sciatic nerve.
    Pain, 135(3): 221-31. [Abstract] [Full-text]
13. Intrauterine growth restriction: fetal programming of hypertension and kidney disease.
    Adv Chronic Kidney Dis, 15(2): 101-6. [Abstract] [Full-text]
14. Is psychosocial stress in first ongoing pregnancies associated with pre-eclampsia and gestational hypertension?
    BJOG, 115(5): 607-15. [Abstract] [Full-text]
15. Study of the propensity for hemorrhage in Hispanic Americans with stroke.
    J Stroke Cerebrovasc Dis, 17(2): 58-63. [Abstract] [Full-text]
16. The efficacy of a clinic-based behavioral nutrition intervention emphasizing a DASH-type diet for adolescents with elevated blood pressure.
    J Pediatr, 152(4): 494-501. [Abstract] [Full-text]
17. Associations among obesity, blood pressure, and left ventricular mass.
    J Pediatr, 152(4): 489-93. [Abstract] [Full-text]
18. Improving hypertension control in diabetes mellitus: the effects of collaborative and proactive health communication.
    Circulation, 117(11): 1361-8. [Abstract] [Full-text]
19. The RGS2 gene product from a candidate hypertension allele shows decreased plasma membrane association and inhibition of Gq.
    Mol Pharmacol, 73(4): 1037-43. [Abstract] [Full-text]
20. Aliskiren: clinical experience and future perspectives of renin inhibition.
    Expert Opin Pharmacother, 9(5): 825-37. [Abstract] [Full-text]
21. High vascular pressure-induced lung injury requires P450 epoxygenase-dependent activation of TRPV4.
    Am J Respir Cell Mol Biol, 38(4): 386-92. [Abstract] [Full-text]
22. Investigating the association between K198N coding polymorphism in EDN1 and hypertension, lipoprotein levels, the metabolic syndrome and cardiovascular disease.
    Hum Genet, 123(3): 307-13. [Abstract] [Full-text]
23. Haplotypic analysis of Wellcome Trust Case Control Consortium data.
    Hum Genet, 123(3): 273-80. [Abstract] [Full-text]
24. Novel use of Kaplan-Meier methods to explain age and gender differences in hypertension control rates.
    Hypertension, 51(4): 841-7. [Abstract] [Full-text]
25. Association between thrombotic microangiopathy and reduced ADAMTS13 activity in malignant hypertension.
    Hypertension, 51(4): 862-6. [Abstract] [Full-text]
26. Pediatric antihypertensive trial failures: analysis of end points and dose range.
    Hypertension, 51(4): 834-40. [Abstract] [Full-text]
27. Nighttime blood pressure and nocturnal dipping are associated with daytime urinary sodium excretion in African subjects.
    Hypertension, 51(4): 891-8. [Abstract] [Full-text]
28. Renal regional proteomes in young Dahl salt-sensitive rats.
    Hypertension, 51(4): 899-904. [Abstract] [Full-text]
29. Glutathione peroxidase-1 plays a major role in protecting against angiotensin II-induced vascular dysfunction.
    Hypertension, 51(4): 872-7. [Abstract] [Full-text]
30. Birth weight relates to salt sensitivity of blood pressure in healthy adults.
    Hypertension, 51(4): 928-32. [Abstract] [Full-text]
31. Endogenous melanocortin system activity contributes to the elevated arterial pressure in spontaneously hypertensive rats.
    Hypertension, 51(4): 884-90. [Abstract] [Full-text]
32. Statin treatment in hypercholesterolemic pregnant mice reduces cardiovascular risk factors in their offspring.
    Hypertension, 51(4): 939-44. [Abstract] [Full-text]
33. Interference with PPARgamma signaling causes cerebral vascular dysfunction, hypertrophy, and remodeling.
    Hypertension, 51(4): 867-71. [Abstract] [Full-text]
34. Glucose homeostasis in hypertensive subjects.
    Hypertension, 51(4): 945-9. [Abstract] [Full-text]
35. Safety of placebo controls in pediatric hypertension trials.
    Hypertension, 51(4): 829-33. [Abstract] [Full-text]
36. The Atp1a1 gene from inbred Dahl salt sensitive rats does not contain the A1079T missense transversion.
    Hypertension, 51(4): 922-7. [Abstract] [Full-text]
37. Levels of renal and extrarenal sympathetic drive in angiotensin II-induced hypertension.
    Hypertension, 51(4): 878-83. [Abstract] [Full-text]
38. Low birthweight is associated with narrower arterioles in adults.
    Hypertension, 51(4): 933-8. [Abstract] [Full-text]
39. Pulsatile but not steady component of blood pressure predicts cardiovascular events in coronary patients.
    Hypertension, 51(4): 848-55. [Abstract] [Full-text]
40. History of fetal growth restriction is more strongly associated with severe rather than milder pregnancy-induced hypertension.
    Hypertension, 51(4): 1231-8. [Abstract] [Full-text]
41. Pregnancy reverses hypertensive remodeling of cerebral arteries.
    Hypertension, 51(4): 1052-7. [Abstract] [Full-text]
42. Age- and sodium-sensitive hypertension and sex-dependent renal changes in rats with a reduced nephron number.
    Hypertension, 51(4): 1184-9. [Abstract] [Full-text]
43. Shared constitutional risks for maternal vascular-related pregnancy complications and future cardiovascular disease.
    Hypertension, 51(4): 1034-41. [Abstract] [Full-text]
44. Alcohol consumption and the risk of hypertension in women and men.
    Hypertension, 51(4): 1080-7. [Abstract] [Full-text]
45. Gender difference in blood pressure control and cardiovascular risk factors in Americans with diagnosed hypertension.
    Hypertension, 51(4): 1142-8. [Abstract] [Full-text]
46. Effects of losartan in women with hypertension and left ventricular hypertrophy: results from the Losartan Intervention for Endpoint Reduction in Hypertension Study.
    Hypertension, 51(4): 1103-8. [Abstract] [Full-text]
47. Smaller aortic dimensions do not fully account for the greater pulse pressure in elderly female hypertensives.
    Hypertension, 51(4): 1129-34. [Abstract] [Full-text]
48. Smoking in moderate/severe preeclampsia worsens pregnancy outcome, but smoking cessation limits the damage.
    Hypertension, 51(4): 1042-6. [Abstract] [Full-text]
49. Gender-related difference in arterial elastance during exercise in patients with hypertension.
    Hypertension, 51(4): 1163-9. [Abstract] [Full-text]
50. Low-intensity exercise training delays heart failure and improves survival in female hypertensive heart failure rats.
    Hypertension, 51(4): 1096-102. [Abstract] [Full-text]
51. Chronic tempol prevents hypertension, proteinuria, and poor feto-placental outcomes in BPH/5 mouse model of preeclampsia.
    Hypertension, 51(4): 1058-65. [Abstract] [Full-text]
52. Gender disparities in blood pressure control and cardiovascular care in a national sample of ambulatory care visits.
    Hypertension, 51(4): 1149-55. [Abstract] [Full-text]
53. Gender differences in left ventricular structure and function during antihypertensive treatment: the Losartan Intervention for Endpoint Reduction in Hypertension Study.
    Hypertension, 51(4): 1109-14. [Abstract] [Full-text]
54. Adverse perinatal outcomes and risk factors for preeclampsia in women with chronic hypertension: a prospective study.
    Hypertension, 51(4): 1002-9. [Abstract] [Full-text]
55. Wine polyphenols improve endothelial function in large vessels of female spontaneously hypertensive rats.
    Hypertension, 51(4): 1088-95. [Abstract] [Full-text]
56. Dietary intake of dairy products, calcium, and vitamin D and the risk of hypertension in middle-aged and older women.
    Hypertension, 51(4): 1073-9. [Abstract] [Full-text]
57. Deoxycorticosterone acetate-salt mice exhibit blood pressure-independent sexual dimorphism.
    Hypertension, 51(4): 1177-83. [Abstract] [Full-text]
58. Hemodynamics of increased pulse pressure in older women in the community-based Age, Gene/Environment Susceptibility-Reykjavik Study.
    Hypertension, 51(4): 1123-8. [Abstract] [Full-text]
59. Mean arterial pressure at 11(+0) to 13(+6) weeks in the prediction of preeclampsia.
    Hypertension, 51(4): 1027-33. [Abstract] [Full-text]
60. A health economic analysis of screening and optimal treatment of nephropathy in patients with type 2 diabetes and hypertension in the USA.
    Nephrol Dial Transplant, 23(4): 1216-23. [Abstract] [Full-text]
61. Treatment with the xanthine oxidase inhibitor febuxostat lowers uric acid and alleviates systemic and glomerular hypertension in experimental hyperuricaemia.
    Nephrol Dial Transplant, 23(4): 1179-85. [Abstract] [Full-text]
62. Cobalt ameliorates renal injury in an obese, hypertensive type 2 diabetes rat model.
    Nephrol Dial Transplant, 23(4): 1166-72. [Abstract] [Full-text]
63. Long-term fatal outcomes in subjects with stroke or transient ischemic attack: fourteen-year follow-up of the systolic hypertension in the elderly program.
    Stroke, 39(4): 1084-9. [Abstract] [Full-text]
64. Risk of aneurysmal subarachnoid hemorrhage: the role of confirmed hypertension.
    Stroke, 39(4): 1344-6. [Abstract] [Full-text]
65. Accessory renal artery stenosis and hypertension: are these correlated? Evaluation using multidetector-row computed tomographic angiography.
    Acta Radiol, 49(3): 278-84. [Abstract] [Full-text]
66. Targeting the calpain/calpastatin system as a new strategy to prevent cardiovascular remodeling in angiotensin II-induced hypertension.
    Circ Res, 102(6): 720-8. [Abstract] [Full-text]
67. Genetic heterogeneity in a susceptible region for essential hypertension among demographically different local populations in Japan.
    Community Genet, 11(3): 150-9. [Abstract] [Full-text]
68. Hypertension awareness, treatment, and control in chronic kidney disease.
    Am J Med, 121(4): 332-40. [Abstract] [Full-text]
69. Oral direct renin inhibition: premise, promise, and potential limitations of a new antihypertensive drug.
    Am J Med, 121(4): 265-71. [Abstract] [Full-text]
70. Transactivation of epidermal growth factor receptor in vascular and renal systems in rats with experimental hyperleptinemia: role in leptin-induced hypertension.
    Biochem Pharmacol, 75(8): 1623-38. [Abstract] [Full-text]
71. Clinical implications of white-coat effect among patients attending at a lipid clinic.
    Atherosclerosis, 197(2): 904-9. [Abstract] [Full-text]
72. Microparticles derived from endothelial progenitor cells in patients at different cardiovascular risk.
    Atherosclerosis, 197(2): 757-67. [Abstract] [Full-text]
73. Integrated evaluation of hypertensive patients with cardiovascular magnetic resonance.
    Int J Cardiol, 125(3): 383-90. [Abstract] [Full-text]

© 2004-2008 Hypertension Research Today. All Rights Reserved.